Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Gagnez 10$ en espèces pour chaque ami Pro+ que vous recommandez !

AstraZeneca PLC

AstraZeneca PLC

AZNCF · PINK
AZNCF · PINK

Gains suivants: 29 juil. 2025

139.70
USD-2.32-1.63%

Date

Tickers

Gros titre

Source

    AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans

    MarketWatch

      AstraZeneca will invest US$50bn in the US to expand manufacturing and research

      Forexlive

        AstraZeneca shares show signs of life after successful trials of hypertension drug

        MarketWatch

          FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC

          CNBC

            AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year. https://t.co/b5hOwTxWaU https://t.co/Wq5EsZGLK5

            Reuters
            @Reuters

              AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition

              SeekingAlpha

                FibroGen sells China unit to AstraZeneca for $160 million

                SeekingAlpha

                  AstraZeneca's Enhertu breast cancer drug added to China's state insurance list https://t.co/ANXcJ37J86 https://t.co/a5p6npwgWs

                  Reuters
                  @Reuters

                    Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

                    CNBC

                      AstraZeneca $AZN Q3 2024 earnings were released today before the market opened: - Revenue: $13.56B vs $13.09B - EPS: $1.04 vs $1.03 https://t.co/L9YMcRERaB

                      Benzinga
                      @Benzinga

                        AstraZeneca says detained China head has lawyer, but company still in dark https://t.co/e0JZ5gcq4d https://t.co/lqYDxOEImo

                        Reuters
                        @Reuters

                          AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

                          MarketWatch

                            AstraZeneca to pay up to $2 billion to license cardiovascular drug

                            MarketWatch

                              Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line https://t.co/xnIivIV4Db https://t.co/myFZAy8W5A

                              Reuters
                              @Reuters

                                US FDA approves AstraZeneca's non-small cell lung cancer treatment https://t.co/mkQJ7SUj5c https://t.co/d9xgiaNCJh

                                Reuters
                                @Reuters

                                  Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030

                                  CNBC

                                    AstraZeneca completes acquisition of Fusion Pharmaceuticals

                                    SeekingAlpha

                                      Ontario court approves AstraZeneca/Fusion acquisition plan

                                      SeekingAlpha

                                        Fusion shareholders give green light to AstraZeneca acquisition

                                        SeekingAlpha

                                          AstraZeneca to build $1.5 billion cancer drug manufacturing plant in Singapore - Reuters

                                          Reuters

                                            Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial https://t.co/1HCc8JsuZy https://t.co/bHfQ2WNCOK

                                            Reuters
                                            @Reuters

                                              AstraZeneca to increase 2024 dividend by 7% on strong growth https://t.co/EwtVdAukKA https://t.co/0HTPRgW6KL

                                              Reuters
                                              @Reuters

                                                AstraZeneca will buy Fusion Pharmaceuticals for ~$2B

                                                SeekingAlpha

                                                  AstraZeneca to expand rare disease pipeline with $1.05B Amolyt Pharma acquisition

                                                  SeekingAlpha

                                                    Gracell Biotechnologies receives shareholder approval for merger with AstraZeneca

                                                    SeekingAlpha

                                                      U.S. FDA approves AstraZeneca's Tagrisso-chemo combo https://t.co/KFPYOpWTGR https://t.co/RPuUvz1XQ1

                                                      Reuters
                                                      @Reuters

                                                        Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled

                                                        SeekingAlpha

                                                          Sell AstraZeneca, says UBS, which upgrades European rivals including GSK

                                                          MarketWatch

                                                            AstraZeneca to buy Gracell Biotechnologies for $1.2 billion

                                                            SeekingAlpha

                                                              Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment

                                                              MarketWatch

                                                                Cytokinetics gains amid report of Novartis, AstraZeneca takeover interest

                                                                SeekingAlpha

                                                                  AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal

                                                                  SeekingAlpha

                                                                    Icosavax enters agreement to be acquired by Astrazeneca

                                                                    SeekingAlpha

                                                                      AstraZeneca partners with AI company to find cure for cancer

                                                                      CoinTelegraph

                                                                        AstraZeneca and Absci Collaborate on AI-Driven Cancer Therapy Development

                                                                        Cryptopolitan

                                                                          Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials

                                                                          Decrypt

                                                                            CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage

                                                                            CNBC

                                                                              AstraZeneca prioritizes US for RSV drug amid surge in cases https://t.co/2KxUhShyqN https://t.co/mxvzb9oZ2C

                                                                              Reuters
                                                                              @Reuters

                                                                                AstraZeneca adds player to obesity drug race, but Eli Lilly remains in the lead

                                                                                CNBC

                                                                                  AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines

                                                                                  MarketWatch

                                                                                    AstraZeneca ups profit outlook on strong cancer drugs demand https://t.co/SJ29rHCteS https://t.co/wVyx5Ey8J0

                                                                                    Reuters
                                                                                    @Reuters

                                                                                      Nanoform Grants AstraZeneca Global STARMAP AI License for Innovative Nanoparticle Medicine Development

                                                                                      Cryptopolitan

                                                                                        As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment

                                                                                        MarketWatch

                                                                                          AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations

                                                                                          CNBC

                                                                                            Stocks making the biggest moves in premarket trading: AstraZeneca, Paramount, Nike and more

                                                                                            CNBC

                                                                                              Stocks making the biggest moves premarket: AstraZeneca, Wayfair, Alibaba and more

                                                                                              CNBC

                                                                                                AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies

                                                                                                MarketWatch

                                                                                                  AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 bln https://t.co/I8WZPzelun https://t.co/xgZG4kGfem

                                                                                                  Reuters
                                                                                                  @Reuters

                                                                                                    AstraZeneca shares slump after Phase 3 lung cancer drug study

                                                                                                    MarketWatch

                                                                                                      Movers & Shakers: Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move

                                                                                                      MarketWatch

                                                                                                      FAQ

                                                                                                      Quel est le prix de l'action AstraZeneca PLC aujourd'hui ?

                                                                                                      Quel est le symbole boursier de AstraZeneca PLC ?

                                                                                                      Le prix de l'action AZNCF est-il en hausse ?

                                                                                                      Quelle est la recommandation des analystes pour AZNCF ?

                                                                                                      Quelle est la capitalisation boursière de AZNCF ?

                                                                                                      Est-ce que AZNCF publie des rapports financiers ?

                                                                                                      Quand est la prochaine date des résultats de AZNCF ?

                                                                                                      Quels ont été les résultats de AZNCF pour le dernier trimestre ?

                                                                                                      Quel a été le chiffre d'affaires de AZNCF pour le dernier trimestre ?

                                                                                                      Quel a été le revenu net de AZNCF pour le dernier trimestre ?

                                                                                                      Est-ce que AZNCF verse des dividendes ?

                                                                                                      Combien d'employés AZNCF a-t-elle ?

                                                                                                      Qu'est-ce que l'EBITDA de AZNCF ?

                                                                                                      Comment acheter des actions de AZNCF ?

                                                                                                      Devrais-je investir dans les actions de AZNCF ?